Jennifer Henrey
Family · Rockford, ILNPI 1942761390
Payments from drug & device makers
Across 96 payments — averaging $29.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$1K
- Lilly USA, LLC$128
- Takeda Pharmaceuticals U.S.A., Inc.$114
- AbbVie$111
- Solventum Corporation$103
- Pfizer$93
- plus $1K from 26 others
What the payments were for
- Travel & lodging$73426%
- Food & beverage$2,07674%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 14 | $1,247 |
| Lilly USA, LLC | 8 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| AbbVie | 5 | $111 |
| Solventum Corporation | 3 | $103 |
| Pfizer | 5 | $93 |
| Sanofi-aventis U.S. LLC | 5 | $92 |
| E.r. Squibb & Sons, L.L.C. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Novo Nordisk | 3 | $58 |
| Urgo Medical North America, LLC | 2 | $57 |
| GSK | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Organogenesis Inc. | 2 | $48 |
| Amneal Pharmaceuticals LLC | 3 | $45 |
| Boehringer Ingelheim | 2 | $44 |
| Merck | 3 | $43 |
| Johnson & Johnson | 2 | $41 |
| Bayer | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 3 | $41 |
| Smith+Nephew | 2 | $38 |
| AstraZeneca | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Novartis | 2 | $30 |
| Medline Industries LP | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $16 |
| KCI USA, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Hollister Incorporated | 1 | $13 |
How this compares
$2,810 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $7,453 |
| XareltoRivaroxaban | 26 | $7,246 |
| MyrbetriqMirabegron | 21 | $4,756 |
| Rosuvastatin Calcium | 21 | $1,180 |
| Bumetanide | 12 | $616 |
| Amlodipine Besylate | 37 | $397 |
| SsdSilver Sulfadiazine | 12 | $240 |
| Doxycycline Hyclate | 32 | $220 |
| Metoprolol Succinate | 11 | $215 |
| Furosemide | 23 | $139 |
| Levothyroxine Sodium | 16 | $132 |
| Losartan Potassium | 13 | $118 |
| Clindamycin Hcl | 13 | $107 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $87 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $93 | $7,45324 claims |
| Johnson & JohnsonXarelto | $41 | $7,24626 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $45 | $13216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,941 family providers in Illinois.
Other family in Rockford
- Suzanne Artale-FritzRockford$63K
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.